47246-4 HIV Antiretroviral therapy Demographic information section

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Demographic information section

Property

-

Time

Pt

System

^Patient

Scale

Set

Method

HIV-ART

Additional Names

Short Name

Demographic information section

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.22

Last Updated

Version 2.67

Order vs. Observation

Order

Panel Type

Panel

Member of these Panels

Related Names

• ID
• Infectious Disease
• InfectiousDisease
• Point in time
• Random

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45394-4 Patient Last (Family) name

Observation ID in Form

AA1c

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Last name

Property

Pn

Time

Pt

System

^Patient

Scale

Nom

Method

Additional Names

Short Name

Patient Last name

Basic Attributes

Class

ADMIN.PATIENT

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.70

Change Reason

Release 2.70: LONG_COMMON_NAME: Added "Patient" to distinguish from the general "Last name" term that does not distinguish between various subjects (patient, provider, contact, etc.).; SHORTNAME: Added "Patient" to distinguish from the general "Last name" term that does not distinguish between various subjects (patient, provider, contact, etc.).;

Order vs. Observation

Both

HL7^® Attributes

HL7^® Field ID

PID-5.1

Member of these Panels

Language Variants Get Info

Related Names

• ADMIN
• ADMIN.PATIENT
• Nominal
• Past
• Person name
• Point in time
• Random

Related Codes

45392-8 Patient First (Given) name

Observation ID in Form

AA1a

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

First name

Property

Pn

Time

Pt

System

^Patient

Scale

Nom

Method

Additional Names

Short Name

Patient First name

Basic Attributes

Class

ADMIN.PATIENT

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.70

Change Reason

Release 2.70: LONG_COMMON_NAME: Added "Patient" to distinguish from the general "First name" term that does not distinguish between various subjects (patient, provider, contact, etc.).; SHORTNAME: Added "Patient" to distinguish from the general "First name" term that does not distinguish between various subjects (patient, provider, contact, etc.).;

Order vs. Observation

Both

HL7^® Attributes

HL7^® Field ID

PID-5.2

Member of these Panels

Language Variants Get Info

Related Names

• ADMIN
• ADMIN.PATIENT
• Given name
• Nominal
• Person name
• Point in time
• Random

Related Codes

46098-0 Gender

Part Descriptions

LP101395-4   Sex
In LOINC, sex refers to the biological sex of an organism, which is most commonly determined based on anatomy and physiology or genetic (chromosome) analysis. Our definition is based on the World Health Organization's definition of sex and gender: sex (male, female) refers to biological and physiological characteristics, and gender (masculine, feminine) refers to socially constructed roles, behaviors, activities, and attributes. (http://www.who.int/gender/whatisgender/en) Source: Regenstrief LOINC, WHO: gender

Observation ID in Form

AA2

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Sex

Property

Type

Time

Pt

System

^Patient

Scale

Nom

Method

Additional Names

Short Name

Sex

Basic Attributes

Class

ADMIN.PATIENT.DEMOG

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.73

Change Reason

Changed Component from 'Gender' to 'Sex' to align with the World Health Organization (WHO) definition of this concept.

Order vs. Observation

Both

Common Test Rank Get Info

2086

HL7^® Attributes

HL7^® Field ID

PID-8

Example Answer List LL1-9

Member of these Panels

Language Variants Get Info

Related Names

• ADMIN
• ADMIN.PATIENT
• ADMIN.PT.DEMOG
• AOEObservation
• Gender
• Nominal
• Point in time
• Random
• Typ

Related Codes

21112-8 Birth date

Observation ID in Form

AA3

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Birth date

Property

TmStp

Time

Pt

System

^Patient

Scale

Qn

Method

Additional Names

Short Name

Birth date

Display Name

Birth date [Date/time]

Consumer Name Alpha Get Info

Birth date

Basic Attributes

Class

MISC

Type

Laboratory

First Released

Version 1.0m

Last Updated

Version 2.73

Order vs. Observation

Observation

Common Test Rank Get Info

1746

HL7^® Attributes

HL7^® Field ID

PID-7.1

Member of these Panels

Language Variants Get Info

Related Names

• Birthdate
• Date and time
• Date of birth
• DOB
• MISC
• Point in time
• QNT
• Quan
• Quant
• Quantitative
• Random
• Time stamp
• Timestamp

Example Units

Related Codes

42077-8 Patient phone number

Term Description

The patient's telephone number.
Source: Regenstrief LOINC

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Phone number

Property

Tele

Time

Pt

System

^Patient

Scale

Nom

Method

Additional Names

Short Name

Phone #

Basic Attributes

Class

ADMIN.PATIENT

Type

Clinical

First Released

Version 2.16

Last Updated

Version 2.73

Change Reason

Revised description and removed NORMATIVE answer list, which only included results for unknown or no phone number available. The answer choices did not include entering the patient's phone number. This term was originally created for the NAACCR v11 tumor registry. The coding instructions in the term description and as part of the answer list are now available as Form Coding Instructions for the term in the instance of the NAACCR version 11 panel [LOINC: 49083-9].

Order vs. Observation

Observation

Common Test Rank Get Info

7124

HL7^® Attributes

HL7^® Field ID

PID-13

Member of these Panels

Language Variants Get Info

Related Names

• ADMIN
• ADMIN.PATIENT
• No
• Nominal
• Num
• Phone #
• Point in time
• Random
• Telecommunication number
• Telephone number

Related Codes

13499-9 HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot

Part Descriptions

LP14307-0   HIV 1
Human immunodeficiency virus is a non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was called HIV and since 1991, the two species have been designated HIV-1 and HIV-2. Source: National Library of Medicine, MeSH 2006

Fully-Specified Name

Component

HIV 1 Ab band pattern

Property

Imp

Time

Pt

System

Ser

Scale

Nom

Method

IB

Additional Names

Short Name

HIV1 Ab Patrn Ser IB-Imp

Display Name

HIV 1 Ab band pattern IB (S) [Interp]

Consumer Name Alpha Get Info

HIV 1 antibody band pattern, Blood

Basic Attributes

Class

MICRO

Type

Laboratory

First Released

Version 1.0j-a

Last Updated

Version 2.73

Order vs. Observation

Observation

Common Test Rank Get Info

897

Member of these Panels

Language Variants Get Info

Related Names

• Ab Patrn
• ABS
• Aby
• AIDS
• Antby
• Anti
• Antibodies
• Antibody
• Autoantibodies
• Autoantibody
• Bands
• Blt
• bnd
• HIV type 1
• HIV type I
• HIV1
• Human immunodeficiency virus
• i
• ID
• IMMUNE BLOT
• Immunobl
• Immunoblot
• Impression
• Impression/interpretation of study
• Impressions
• Infectious Disease
• InfectiousDisease
• Interp
• Interpretation
• Microbiology
• Nominal
• Patrn
• Point in time
• Random
• RIBA
• Serum
• SR
• WB
• WBLOT
• West blot
• West blt
• Western blot

31073-0 HIV 2 Ab band pattern [Interpretation] in Serum by Immunoblot

Part Descriptions

LP16716-0   HIV 2
Human immunodeficiency virus is a non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was called HIV and since 1991, the two species have been designated HIV-1 and HIV-2. Source: National Library of Medicine, MeSH 2006

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

HIV 2 Ab band pattern

Property

Imp

Time

Pt

System

Ser

Scale

Nom

Method

IB

Additional Names

Short Name

HIV 2 Ab Patrn Ser IB-Imp

Display Name

HIV 2 Ab band pattern IB (S) [Interp]

Consumer Name Alpha Get Info

HIV 2 antibody band pattern, Blood

Basic Attributes

Class

MICRO

Type

Laboratory

First Released

Version 2.07

Last Updated

Version 2.58

Order vs. Observation

Observation

Member of these Panels

Language Variants Get Info

Related Names

• Ab Patrn
• ABS
• Aby
• AIDS
• Antby
• Anti
• Antibodies
• Antibody
• Autoantibodies
• Autoantibody
• Bands
• Blt
• bnd
• HIV type 2
• HIV type II
• Human immunodeficiency virus
• ID
• II
• Immune blot
• Immunobl
• Immunoblot
• Impression
• Impression/interpretation of study
• Impressions
• Infectious Disease
• InfectiousDisease
• Interp
• Interpretation
• Microbiology
• Nominal
• Patrn
• Point in time
• Random
• RIBA
• Serum
• SR
• WB
• WBLOT
• West blot
• West blt
• Western blot

47249-8 HIV Antiretroviral therapy HIV care and family status section

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

HIV care & family status section

Property

-

Time

Pt

System

^Patient

Scale

Set

Method

HIV-ART

Additional Names

Short Name

HIV care & family status section

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.22

Last Updated

Version 2.67

Order vs. Observation

Order

Panel Type

Panel

Member of these Panels

Related Names

• AIDS
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Point in time
• Random

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45250-8 HIV confirmation facility Address

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

HIV confirmation facility

Property

Addr

Time

Pt

System

Facility

Scale

Nom

Method

Reported

Additional Names

Short Name

HIV confirmation facility Add

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Member of these Panels

Related Names

• Address
• AIDS
• ART
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Nominal
• Point in time
• Random

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45251-6 HIV confirmation facility

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

HIV confirmation facility

Property

ID

Time

Pt

System

Facility

Scale

Nom

Method

Reported

Additional Names

Short Name

HIV confirmation facility

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Member of these Panels

Related Names

• AIDS
• ART
• Human immunodeficiency virus
• ID
• Ident
• Identifier
• Infectious Disease
• InfectiousDisease
• Nominal
• Point in time
• Random

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45252-4 Institutional entry point HIV treatment

Term Description

The type of institutional setting in which the person started anti-retroval therapy (ART).
Source: Regenstrief LOINC

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Institutional entry point HIV Rx

Property

Type

Time

Pt

System

Facility

Scale

Nom

Method

Reported

Additional Names

Short Name

Inst entry point HIV Rx

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Normative Answer List LL350-0

Member of these Panels

Related Names

• AIDS
• Anti-retroviral therapy
• ART
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Inst entry point HIV Rx
• Nominal
• Point in time
• Random
• Treatment
• Typ

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45230-0 District where patient entered HIV treatment

Term Description

The local administrative area, e.g., county.
Source: Regenstrief LOINC

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

District where patient entered HIV Rx

Property

ID

Time

Pt

System

^Patient

Scale

Nom

Method

Reported

Additional Names

Short Name

District where patient entered HIV Rx

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Member of these Panels

Related Names

• AIDS
• Anti-retroviral therapy
• ART
• Human immunodeficiency virus
• ID
• Ident
• Identifier
• Infectious Disease
• InfectiousDisease
• Nominal
• Point in time
• Random
• Treatment

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

47248-0 HIV Antiretroviral therapy Antiretroviral therapy status section

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Antiretroviral therapy status section

Property

-

Time

Pt

System

^Patient

Scale

Set

Method

HIV-ART

Additional Names

Short Name

Antiretroviral therapy status section

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.22

Last Updated

Version 2.67

Order vs. Observation

Order

Panel Type

Panel

Member of these Panels

Related Names

• ID
• Infectious Disease
• InfectiousDisease
• Point in time
• Random

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45231-8 HIV treatment prior to enrollment

Term Description

Captures information regarding any previous ART.
Source: Regenstrief LOINC

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

HIV Rx prior to enrollment

Property

Type

Time

Pt

System

^Patient

Scale

Nom

Method

Reported

Additional Names

Short Name

HIV Rx prior to enrollment

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Normative Answer List LL351-8

Member of these Panels

Related Names

• AIDS
• Anti-retroviral therapy
• ART
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Nominal
• Point in time
• Random
• Treatment
• Typ

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

47240-7 Date determined medically eligible to start HIV treatment

Term Description

Date determined medically eligible to start ART
Source: Regenstrief LOINC

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Date determined medically eligible to start HIV Rx

Property

Date

Time

Pt

System

^Patient

Scale

Qn

Method

Reported

Additional Names

Short Name

Date eligible to start HIV Rx

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.22

Last Updated

Version 2.67

Order vs. Observation

Observation

Member of these Panels

Related Names

• AIDS
• Anti-retroviral therapy
• Date eligible to start HIV Rx
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Point in time
• QNT
• Quan
• Quant
• Quantitative
• Random
• Started
• Treatment

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45232-6 Reason medically eligible for HIV treatment

Term Description

Why patient is medically eligible for anti-retroviral therapy
Source: Regenstrief LOINC

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Reason medically eligible for HIV Rx

Property

Find

Time

Pt

System

^Patient

Scale

Nom

Method

Reported

Additional Names

Short Name

Reason medically eligible for HIV Rx

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Normative Answer List LL352-6

Member of these Panels

Related Names

• AIDS
• Anti-retroviral therapy
• ART
• Finding
• Findings
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Nominal
• Point in time
• Random
• Treatment

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45233-4 World Health Organization HIV stage

Term Description

Accepted coding values are 1,2,3,4, and T1,T2,T3,T4, both sets basically mean the same thing, the T prefix indicates that the individual is being treated with ARVs.
Source: Regenstrief LOINC

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

WHO HIV stage

Property

Find

Time

Pt

System

^Patient

Scale

Ord

Method

Reported

Additional Names

Short Name

WHO HIV stage

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Member of these Panels

Related Names

• AIDS
• ART
• Finding
• Findings
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Ordinal
• Point in time
• QL
• Qual
• Qualitative
• Random
• Screen
• World Heatlth Organization

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

32516-7 CD3+CD4+ (T4 helper) cells/100 cells in Specimen

Part Descriptions

LP14441-7   Cells.CD3+CD4+
HIV infection decreases the number of CD3+ CD4+ lymphocytes (also called CD4 T cells or T4 helper cells) while increasing (momentarily) the numbers of CD3+CD8+ lymphocytes (called CD8 T lymphocytes or cytotoxic T cells). Thus the ratio of CD4/CD8 lymphocytes is decreased. These counts are used for prognostic purposes and to guide in the retroviral therapy. CDC has emphasized since 1997 that the number of CD3+ lymphocytes is necessary in addition to the number of CD4+ cells to reliably identify the T4 helper cells and the number of CD8+ cells. Laboratory reports that include only CD4 or only CD8 in their nomenclature are most likely really measuring CD3+CD4+ cells and CD3+CD8+ cells, respectively. Source: Regenstrief Help

LP14441-7   Cells.CD3+CD4+
HIV infection decreases the number of CD4 T-cells, also called T4 helper cells, the ratio of CD4 to CD8 T-cells and the number of CD8+ T-cells. These counts are ordered frequently to guide decisions about anti-retroviral therapy. Laboratories usually report both percentage and absolute count. When you map CD4 and CD8 markers, be careful! Since at least 1997, CDC has required the detection of both CD3+ and CD4+ to identify T4 helper cells, because the CD3 marker is needed to identify T-cell . So, any tests that report T4 helper cells are really reporting cells that carry BOTH the CD3+ and the CD4+ markers. The measure name may be CD3+ CD4+ cells, CD4+ marker, T4 cells or even just CD4+ (a misnomer). Exactly analogous rules apply to CD8+. Measures that include only CD4 or only CD8 in their name are really measuring CD3+CD4+ cells or CD3+CD8+ cells, respectively and should be reported with the LOINC code that includes both of those markers. The panel named T cell subsets will usually contain both CD3 + CD4 and CD3 + CD8 counts. These names assume that one has already gated to lymphocytes only. Lymphocytes are identified by CD45 markers. So a CD45+CD3+CD4+ is a more complicated way to name CD3+C4+ cells and in the context of looking for CD4 helper T cells they are the same . The same applies to other flow cytometer measures that are looking only at lymphocytes (B-cells, NK cells, etc). Source: Regenstrief Help

LP14443-3   CD4
Found on helper T-cells; weakly expressed on monocytes.
Associated with some mature T-cell neoplasms, including most cases of T-cell CLL/prolymphocytic leukemia, peripheral
T-cell lymphoma, adult T-cell leukemia/lymphoma and Sézary syndrome/mycosis fungoides Source: Regenstrief LOINC

Fully-Specified Name

Component

Cells.CD3+CD4+/100 cells

Property

NFr

Time

Pt

System

XXX

Scale

Qn

Method

Additional Names

Short Name

CD3+CD4+ Cells NFr Spec

Display Name

CD3+CD4+ (T4 helper) cells/100 cells (Specimen)

Consumer Name Alpha Get Info

CD3+CD4+ (T4 Helper) Cells per 100 cells, Specimen

Basic Attributes

Class

CELLMARK

Type

Laboratory

First Released

Version 2.08

Last Updated

Version 2.73

Order vs. Observation

Observation

Common Test Rank Get Info

6202

Member of these Panels

Language Variants Get Info

Related Names

• CD3 Cells
• CD3+CD4+ Cells
• CD3-CD4+
• CD4+ T cells
• Cell
• CELL MARKERS
• Cellularity
• Gated cells
• Helper T cells
• Inducer T cells
• L3T4
• Leu3
• Leu-3
• Leu4
• Leu-4
• Misc
• Miscellaneous
• Number fraction
• Other
• Percent
• Point in time
• QNT
• Quan
• Quant
• Quantitative
• Random
• Spec
• T3
• T4
• T-4
• T4 helper/inducer cells
• To be specified in another part of the message
• Unspecified
• W3/25

Example Units

32515-9 CD3+CD4+ (T4 helper) cells [#/volume] in Specimen

Part Descriptions

LP14441-7   Cells.CD3+CD4+
HIV infection decreases the number of CD3+ CD4+ lymphocytes (also called CD4 T cells or T4 helper cells) while increasing (momentarily) the numbers of CD3+CD8+ lymphocytes (called CD8 T lymphocytes or cytotoxic T cells). Thus the ratio of CD4/CD8 lymphocytes is decreased. These counts are used for prognostic purposes and to guide in the retroviral therapy. CDC has emphasized since 1997 that the number of CD3+ lymphocytes is necessary in addition to the number of CD4+ cells to reliably identify the T4 helper cells and the number of CD8+ cells. Laboratory reports that include only CD4 or only CD8 in their nomenclature are most likely really measuring CD3+CD4+ cells and CD3+CD8+ cells, respectively. Source: Regenstrief Help

LP14441-7   Cells.CD3+CD4+
HIV infection decreases the number of CD4 T-cells, also called T4 helper cells, the ratio of CD4 to CD8 T-cells and the number of CD8+ T-cells. These counts are ordered frequently to guide decisions about anti-retroviral therapy. Laboratories usually report both percentage and absolute count. When you map CD4 and CD8 markers, be careful! Since at least 1997, CDC has required the detection of both CD3+ and CD4+ to identify T4 helper cells, because the CD3 marker is needed to identify T-cell . So, any tests that report T4 helper cells are really reporting cells that carry BOTH the CD3+ and the CD4+ markers. The measure name may be CD3+ CD4+ cells, CD4+ marker, T4 cells or even just CD4+ (a misnomer). Exactly analogous rules apply to CD8+. Measures that include only CD4 or only CD8 in their name are really measuring CD3+CD4+ cells or CD3+CD8+ cells, respectively and should be reported with the LOINC code that includes both of those markers. The panel named T cell subsets will usually contain both CD3 + CD4 and CD3 + CD8 counts. These names assume that one has already gated to lymphocytes only. Lymphocytes are identified by CD45 markers. So a CD45+CD3+CD4+ is a more complicated way to name CD3+C4+ cells and in the context of looking for CD4 helper T cells they are the same . The same applies to other flow cytometer measures that are looking only at lymphocytes (B-cells, NK cells, etc). Source: Regenstrief Help

LP14443-3   CD4
Found on helper T-cells; weakly expressed on monocytes.
Associated with some mature T-cell neoplasms, including most cases of T-cell CLL/prolymphocytic leukemia, peripheral
T-cell lymphoma, adult T-cell leukemia/lymphoma and Sézary syndrome/mycosis fungoides Source: Regenstrief LOINC

Reference Information

Fully-Specified Name

Component

Cells.CD3+CD4+

Property

NCnc

Time

Pt

System

XXX

Scale

Qn

Method

Additional Names

Short Name

CD3+CD4+ Cells # Spec

Display Name

CD3+CD4+ (T4 helper) cells (Specimen) [#/Vol]

Consumer Name Alpha Get Info

CD3+CD4+ (T4 Helper) Cells, Specimen

Basic Attributes

Class

CELLMARK

Type

Laboratory

First Released

Version 2.08

Last Updated

Version 2.73

Order vs. Observation

Observation

Common Test Rank Get Info

1894

Member of these Panels

Language Variants Get Info

Related Names

• #
• ABS
• absolute
• absolutes
• CD3 Cells
• CD3+CD4+ Cells
• CD3-CD4+
• CD4+ T cells
• Cell
• CELL MARKERS
• Cellularity
• Cnt
• Count
• Count/volume
• CT
• Helper T cells
• Inducer T cells
• L3T4
• Leu3
• Leu-3
• Leu4
• Leu-4
• Misc
• Miscellaneous
• Number concentration
• Number Concentration (count/vol)
• Other
• Point in time
• QNT
• Quan
• Quant
• Quantitative
• Random
• Spec
• T3
• T4
• T-4
• T4 helper/inducer cells
• To be specified in another part of the message
• Unspecified
• W3/25

Example Units

47241-5 Date determined medically eligible and ready to start HIV treatment

Term Description

Date determined medically eligible and ready to start ART
Source: Regenstrief LOINC

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Date determined medically eligible and ready to start HIV Rx

Property

Date

Time

Pt

System

^Patient

Scale

Qn

Method

Reported

Additional Names

Short Name

Date eligible & ready to start HIV Rx

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.22

Last Updated

Version 2.67

Order vs. Observation

Observation

Member of these Panels

Related Names

• AIDS
• Anti-retroviral therapy
• Date eligible & ready to start HIV Rx
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Point in time
• QNT
• Quan
• Quant
• Quantitative
• Random
• Started
• Treatment

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45234-2 Date eligible and selected to start HIV treatment

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Date eligible and selected to start HIV Rx

Property

Date

Time

Pt

System

^Patient

Scale

Qn

Method

Reported

Additional Names

Short Name

Date eligible & selected to start HIV Rx

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Member of these Panels

Related Names

• AIDS
• Anti-retroviral therapy
• Date eligible & selected to start HIV Rx
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Point in time
• QNT
• Quan
• Quant
• Quantitative
• Random
• Started
• Treatment

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45253-2 HIV treatment prior clinic transferred from Address

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

HIV Rx prior clinic transferred from

Property

Addr

Time

Pt

System

Facility

Scale

Nom

Method

Reported

Additional Names

Short Name

HIV Rx prior clinic transferred from Add

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Member of these Panels

Related Names

• Address
• Admitted
• AIDS
• Anti-retroviral therapy
• ART
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Nominal
• Point in time
• Random
• Treatment

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45254-0 HIV treatment prior clinic transferred from

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

HIV Rx prior clinic transferred from

Property

ID

Time

Pt

System

Facility

Scale

Nom

Method

Reported

Additional Names

Short Name

HIV Rx prior clinic

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Member of these Panels

Related Names

• Admitted
• AIDS
• Anti-retroviral therapy
• ART
• Human immunodeficiency virus
• ID
• Ident
• Identifier
• Infectious Disease
• InfectiousDisease
• Nominal
• Point in time
• Random
• Treatment

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45235-9 Date original clinic HIV treatment start

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Date original clinic HIV Rx start

Property

Date

Time

Pt

System

^Patient

Scale

Qn

Method

Reported

Additional Names

Short Name

Date original clinic HIV Rx start

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Member of these Panels

Related Names

• AIDS
• Anti-retroviral therapy
• Human immunodeficiency virus
• ID
• Infectious Disease
• InfectiousDisease
• Point in time
• QNT
• Quan
• Quant
• Quantitative
• Random
• Started
• Treatment

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

45236-7 HIV treatment cohort

Term Description

ART start-up group which consists of all patients starting ART in the same month.
Source: Regenstrief LOINC

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

HIV Rx cohort

Property

ID

Time

Pt

System

^Patient

Scale

Nom

Method

Reported

Additional Names

Short Name

HIV Rx cohort

Basic Attributes

Class

ART

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.67

Member of these Panels

Related Names

• AIDS
• Anti-retroviral therapy
• ART
• Human immunodeficiency virus
• ID
• Ident
• Identifier
• Infectious Disease
• InfectiousDisease
• Nominal
• Point in time
• Random
• Treatment

Copyright

Organization

World Health Organization (WHO)

Copyright

Copyright © 2006 World Health Organization.

Terms of Use

Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

URL

https://www.who.int/about/policies/publishing/copyright

8671-0 History of Functional status

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Functional status

Property

Hx

Time

Pt

System

^Patient

Scale

Nom

Method

Additional Names

Short Name

Hx of Functional status

Basic Attributes

Class

H&P.HX

Type

Clinical

First Released

Version 1.0h(3)

Last Updated

Version 2.56

Change Reason

Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision

Preferred Answer List LL2963-8

Externally Defined

Yes

Code System

SCT

Code System OID

1.3.6.1.4.1.12009.10.1.1896

Link to External List

http://snomed.info/sct

Member of these Panels

Language Variants Get Info

Related Names

• H+P
• H+P.HX
• History
• Nominal
• P prime
• Point in time
• Random

18833-4 First Body weight

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Body weight

Property

Mass

Time

Enctr^frst

System

^Patient

Scale

Qn

Method

Measured

Basic Attributes

Class

ATTACH.CLINRPT

Type

Claims Attachments

First Released

Version 1.0l

Last Updated

Version 2.73

Common Test Rank Get Info

17679

Member of these Panels

Language Variants Get Info

Related Names

• 1st
• ATTACH
• ATTACH.CLINRPT
• Bdy weight
• bod
• Bodies
• Encounter
• QNT
• Quan
• Quant
• Quantitative
• Wt

Example Units

3137-7 Body height Measured

Observation ID in Form

K2a

Type of Entry

Question expects user entry - requires response [Q]

Fully-Specified Name

Component

Body height

Property

Len

Time

Pt

System

^Patient

Scale

Qn

Method

Measured

Additional Names

Short Name

Body height Measured

Basic Attributes

Class

BDYHGT.ATOM

Type

Clinical

First Released

Version 1.0

Last Updated

Version 2.73

Order vs. Observation

Both

Common Test Rank Get Info

372

Member of these Panels